MediXall Group, Inc.: 10-Q filed 2014-12-16

Name: MediXall Group, Inc.: 10-Q filed 2014-12-16
Creator: MediXall Group, Inc.

What MediXall Group, Inc. reported in its quarterly report filed 2014-12-16 (fiscal Q3 2014): 20 published measures, 45 facts as tagged in accession 0001553350-14-001513.

This filing

Form: 10-Q (quarterly report)
Filed: 2014-12-16
Fiscal period: fiscal Q3 2014
Accession: 0001553350-14-001513 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All MediXall Group, Inc. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

Period	Value	Unit	Days
At 2014-09-30	544	USD
At 2013-12-31	45,479	USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

Period	Value	Unit
At 2014-09-30	-965,777	USD
At 2013-12-31	-408,418	USD
At 2012-12-31	-431,296	USD
At 2011-12-31	-355,339	USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

Period	Value	Unit	Days
2014-07-01 to 2014-09-30	-157,504	USD	92
2014-01-01 to 2014-09-30	-605,699	USD	273
2013-01-01 to 2013-12-31	-988,194	USD	365
2013-07-01 to 2013-09-30	-532,607	USD	92
2013-01-01 to 2013-09-30	-775,647	USD	273
2012-01-01 to 2012-12-31	-151,907	USD	366

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

Period	Value	Unit	Days
2014-01-01 to 2014-09-30	-48,325	USD	273
2013-01-01 to 2013-09-30	11,713	USD	273

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

Period	Value	Unit	Days
2013-01-01 to 2013-09-30	42,500	USD	273

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

Period	Value	Unit	Days
At 2014-09-30	-1,593,893	USD
At 2013-12-31	-988,194	USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

Period	Value	Unit	Days
2013-01-01 to 2013-09-30	512,582	USD	273

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

Period	Value	Unit	Days
2014-07-01 to 2014-09-30	-157,504	USD	92
2014-01-01 to 2014-09-30	-605,699	USD	273
2013-07-01 to 2013-09-30	-532,607	USD	92
2013-01-01 to 2013-09-30	-766,515	USD	273

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

Period	Value	Unit	Days
At 2014-09-30	544	USD
At 2013-12-31	45,479	USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

Period	Value	Unit	Days
2013-01-01 to 2013-09-30	9,132	USD	273

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

Period	Value	Unit	Days
At 2014-09-30	966,321	USD
At 2013-12-31	453,897	USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

Period	Value	Unit	Days
At 2014-09-30	233,265	USD
At 2013-12-31	58,936	USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

Period	Value	Unit	Days
2014-07-01 to 2014-09-30	157,504	USD	92
2014-01-01 to 2014-09-30	605,699	USD	273
2013-07-01 to 2013-09-30	532,607	USD	92
2013-01-01 to 2013-09-30	809,015	USD	273

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

Period	Value	Unit	Days
At 2014-09-30	37,872,068	shares
At 2013-12-31	37,752,068	shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

Period	Value	Unit	Days
At 2014-09-30	3,606,557	USD
At 2013-12-31	3,558,337	USD

Long-term debt

Long-term borrowings under this concept, which can include the current portion depending on presentation. It is not total liabilities and may exclude leases and other obligations.

Period	Value	Unit	Days
At 2013-06-24	170,000	USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

Period	Value	Unit	Days
At 2014-09-30	38,334	USD
At 2013-12-31	43,822	USD

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

Period	Value	Unit	Days
2013-01-01 to 2013-09-30	-9,132	USD	273

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

Period	Value	Unit	Days
2014-01-01 to 2014-09-30	3,340	USD	273
2013-01-01 to 2013-09-30	102,500	USD	273

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

Period	Value	Unit	Days
2014-01-01 to 2014-09-30	174,330	USD	273
2013-01-01 to 2013-09-30	642	USD	273

Inspect the source

Entity: MediXall Group, Inc. / CIK 0001601280
Captured: 2026-09-21T17:20:21.643Z
SEC response SHA-256: b6322b58d999c8a74b96274fe9d2bf7196a7223cedbe45a09c2d28d5c34a5827

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001601280.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))